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Background: Previous studies reported an association
between weak habituation of skin conductance orienting re-
sponse and psychosis proneness. The aimof this studywas to
investigate the relationship among neuregulin 1 (NRG1)–
stimulated AKT phosphorylation (a putative marker of psy-
chosis), orienting response habituation, delusional ideas,
anxiety, and depression in nonclinical individuals.Methods:
One hundred twenty individuals participated in the skin
conductance measurements. Weak and strong habituators
were compared on measures of NRG1-stimulated AKT
phosphorylation in B lymphoblasts, delusional ideas, anx-
iety, and depression. The predictors of delusional ideas
were determined by multiple regression analysis. Results:
Weak habituators displayed higher levels of delusional
ideas/anxiety and a lower ratio of phosphorylated AKT
as compared with strong habituators. There were 3 signif-
icant predictors of delusional ideas: decreased habituation,
NRG1-induced AKT phosphorylation, and anxiety. Age,
gender, education, IQ, and depression did not predict
delusional ideas. Conclusions: These results suggest that
decreased habituation of arousal, NRG1-induced AKT
phosphorylation, and anxiety are related to delusional ide-
ation in the general population.
Key words: neuregulin 1/AKT/psychosis proneness/
delusional ideation/skin conductance/orienting response
Introduction
There is epidemiological evidence that psychosis-like
symptoms are more common in the nonclinical popula-
tion than previously believed, which may indicate an eti-
ological continuity in psychotic symptoms.1 At the
physiological level, psychosis vulnerability may be as-
sociated with the decreased adaptation of autonomic
arousal. Allen et al2 provided physiological evidence
for the hypothesis of psychosis continuum by examining
the relationship between the adaptation of the skin con-
ductance orienting response (autonomic arousal) and de-
lusional ideation in nonclinical individuals. During this
experiment, participants were presented with a series of
auditory stimuli parallel with the measurement of the
electrodermal orienting response. The orienting response
was gradually reduced with stimulus repetition, which
reflects the adaptation of autonomic arousal. Allen
et al2 demonstrated that individuals who showed less ad-
aptation (weak habituators) achieved higher scores on
a scale of delusional ideation (especially for conviction
and preoccupation), which may be a marker of psychosis
proneness. This finding is similar to that found in schizo-
phrenia-spectrum disorders. Patients with schizophrenia
who experienced hallucinations and delusions3,4 and indi-
viduals with schizotypal personality disorder5,6 displayed
a similarly weak adaptation of the orienting response,
which supports the hypothesis of psychosis continuum.
Finally, Hazlett et al7 demonstrated abnormal electroder-
mal activity in the prodromal phase of psychosis (for
reviews of early studies on electrodermal activity and psy-
chosis vulnerability and schizotypy, see Ohman8 and
Gruzelier and Raine9).
One of the most difficult challenges is to understand
the neurobiological bases of psychosis continuum and
to explore its relationship with physiological parameters
(eg, the orienting response), molecular-cellular features,
and subjective experiences such as delusional ideation
and emotional symptoms. The crucial issue is that a valid
peripheral marker of psychosis is still missing. However,
the data of Sei et al10 on neuregulin 1 (NRG1)–inducted
cell migration and AKT phosphorylation in peripheral B
lymphoblasts of patients with schizophrenia are promis-
ing. NRG1 and its receptor ErbB4 play an important role
in neurodevelopment and synaptic plasticity and may be
implicated in psychotic disorders.11,12 NRG1 activates
the Ras-MAPK and phosphatidylinositol-3 kinase–
protein kinase B (PI3K–PKB/AKT) intracellular signal-
ing pathways through ErbB receptors.13 This pathway
may be important in the regulation of cell migration
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and cell adhesion, which are potentially implicated in the
pathophysiology of schizophrenia.10,14
Genetic studies indicated that various polymorphisms
of the NRG1 gene are associated with schizophrenia and
bipolar disorder, although the evidence is not conclu-
sive.15,16 Postmortem studies have revealed altered ex-
pression of different isoforms of NRG1 in the brain of
patients with schizophrenia, but these alterations are
not consistently linked to functional polymorphisms.17
Some of these genetic variants have been linked to de-
creased brain activation during cognitive tasks and to in-
creased risk of psychosis conversion in people who
displayed subclinical psychosis-like symptoms (‘‘at-
risk’’ mental state).18,19 Sei et al10 demonstrated that
NRG1-induced migration of B lymphoblasts of patients
with schizophrenia is significantly decreased compared
with control individuals. This impaired migration was
related to reduced NRG1-stimulated AKT phosphoryla-
tion in the patients and was associated with polymor-
phisms of the NRG1 and catechol-O-methyltransferase
(COMT) genes and with an epistatic interaction of these
genes.10 The robust reduction of NRG1-induced AKT
phosphorylation in the patients is a promising peripheral
marker of psychosis, especially because AKT-related sig-
naling pathways have been implicated in the pathophys-
iology of schizophrenia.20
In this study, we measured delusional ideation, emo-
tional symptoms (depression and anxiety), habituation
of autonomic arousal, and NRG1-induced AKT phos-
phorylation in nonclinical individuals. We hypothesized
that delusional ideation is associated with weaker habit-
uation of arousal and decreased AKT phosphorylation.
Methods
Participants
One hundred twenty volunteers, aged between 18 and 45
years, with negative history for psychiatric and neurolog-
ical disorders participated in the study. They were
recruited via internet community networks or were mem-
bers of the hospital staff and their acquaintances. All par-
ticipants were screened for psychiatric disorders using the
Structured Clinical Interview for Diagnostic and Statisti-
cal Manual of Mental Disorders (Fourth Edition) Axis
I disorders (SCID-CV).21 Individuals with psychiatric
disorders, including psychoactive substance misuse,
were excluded from the study. General intellectual func-
tions were assessed by the revised version of theWechsler
Adult Intelligence Scale (WAIS-R).22 All participants
gave written informed consent, and the study was
approved by the local ethics board.
Assessment of Delusional Ideation and Emotional
Symptoms
Delusional ideas were measured using the Peters et al.
Delusion Inventory (PDI),23 which is a self-report instru-
ment consisting of modified items from the Present State
Examination.24 The PDI assesses delusional conviction,
preoccupation, and distress. The original scale consists of
40 items, which are divided into 8 categories: (1) delusions
of control; (2) misinterpretations, misidentification, and
delusions of reference; (3) delusions of persecution; (4)
expansive delusions; (5) delusions concerning various
types of influence and primary delusions; (6) other delu-
sions (delusions related to body image and smell); (7)
simple delusions based on guilt, depersonalization, hypo-
chondriasis; (8) thought reading, insertion, echo, broad-
cast. First, the participant was asked a yes-no question
(‘‘Do you ever feel as if people seem to drop hints about
you or say things with a double meaning?’’ or ‘‘Do you
ever feel as if electrical devices such as computers can in-
fluence the way you think?’’). Participants were asked to
fill the conviction, preoccupation, and distress scales only
for the statements that they endorsed (‘‘yes’’ response). In
the case of a ‘‘no’’ response, they were asked to proceed to
the next question without filling in the scales, and a score
of 0 was given. Each dimension was represented by a
5-point Likert scale (from ‘‘Not at all distressing’’ [point 1]
to ‘‘Very distressing’’ [point 5] for distress; from ‘‘Hardly
ever think about it’’ [point 1] to ‘‘Think about it all the
time’’ [point 5] for preoccupation; and from ‘‘Don’t
believe it’s true’’ [point 1] to ‘‘Believe it is absolutely
true’’ [point 5] for conviction). In the present study,
the 21-item version of the PDI was used25. The Cronbach
a was .84, indicating a good internal consistency. The
dependent measure was the total PDI score, which was
the sum of the conviction, preoccupation, and distress
subscales.
Anxiety and depression were measured by the Beck
Anxiety Inventory (BAI)26 and by the Beck Depression
Inventory (BDI)27, respectively.
Orienting Response
To measure the orienting response, the classic method of
Venables and Christie28 was implemented in a modified
version. An in-house made instrument was used that was
linked to a HP workstation. Silver/silver chloride electro-
des were placed on the index and middle fingers of the
dominant hand of the participants. The duration of base-
line recording without any stimulus was 5 minutes. After
the baseline recording, the stimulus presentation began.
Stimuli were 10 consecutive tones presented binaurally
through headphones (80 dB, 800 Hz). The interstimulus
interval varied between 40 and 80 seconds. The skin con-
ductance response was recorded during the baseline pe-
riod and during the orienting response to the tones. The
orienting response was measured in a latency window of
0–5 seconds after stimulus offset. The amplitude thresh-
old was 0.05 lS. Nonrespondents were excluded from
the experiment (12 volunteers not included in the sample
description).
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To define individuals with weak and strong adapta-
tion, the habituation index was calculated for each par-
ticipant. To obtain the index, the orienting response
amplitude of the third trial was subtracted from the am-
plitude of the first trial, given that habituation is the most
pronounced during the first 3 trials.6 Positive values of
the index indicate normal (strong) habituation, whereas
0 or negative values indicate weak habituation.2 Partic-
ipants with positive values were included in the strong ha-
bituation group, and participants with a negative or
0 value were included in the weak habituation group.
The habituation index was rounded to 2 decimal places.
For example, a habituation index of 0.03 would have
been rounded to 0 and included in the low habituation
group2.
NRG1-Induced AKT Phosphorylation
We adopted the protocol of Sei et al.10 B lymphocytes in
the mononuclear cell preparation were transformed by
infection with Epstein-Barr virus and were grown and
maintained as described by Pressman and Rotter29 and
Sei et al.10 B lymphoblasts were stimulated with
NRG1a (296-HR, 65 amino acid residue recombinant
protein from the epidermal growth factor domain of
NRG1a [177–241]; R&D system Inc, Minneapolis,
MN; 200 ng/ml) for 30 minutes. Protein isolated from
the cells was analyzed by Western blotting. To quantify
the level of phosphorylation, the immunoblots were
stained with antibodies specific to phosphorylated
AKT (pAKT)1 at Ser473 (60 kDa) and were then
reprobed with total AKT (both antibodies were pur-
chased from Upstate, Charlottesville, VA; 1 lg/ml).
For the immunoblot analysis, cells were disrupted in Bio-
force homogenizers (buffer: 250 mM Tris–HCl, 100 mM
NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate,
0.5% deoxycholic acid, 1 mM p-nitrophenylguanidino-
benzoate, and protease inhibitor cocktail I and II [Sigma,
Saint Louis, MO]). The homogenized material was incu-
bated for 20 minutes at 41 C, and then was centrifugated
(14000 g for 15 min) to obtain supernatants for further
analysis. Following the collection of supernatants, the
protein samples were separated (sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis on Tris-glycine
gel [Invitrogen, Carlsband, CA]), transferred to polyviny-
lidene difluoride membrane (Millipore Corp, Bedford,
MA), and then probed with the primary antibodies.
The primary antibodies were detected using horseradish
peroxidase–conjugated anti-rabbit IgG antibodies
(Promega, Madison, WI), which was followed by en-
hanced chemiluminescence detection (Amersham Bio-
sciences, Buckinghamshire, UK). The protein bands
within the linear range of the standard curve were im-
aged. The relative optical density was measured using
National Institutes of Health Image software. The depen-
dent measure was the ratio of pAKT and total AKT at
baseline (without NRG1 stimulation) and after NRG1
stimulation (pAKT/AKT). The phosphorylated form/to-
tal ratio was calculated after a quantitative densitometric
analysis of each band within a linear range.10
Data Analysis
The STATISTICA 7.0 software was used for data anal-
ysis (StatSoft Inc, Tulsa, OK). All data were checked
for the normality of distribution using Kolmogorov-
Smirnov tests. In the first analysis, delusional ideation
(PDI), emotional symptoms (BAI, BDI), IQ (WAIS-R),
and demographic parameters were comparedwith a series
of independent 2-tailed t tests in individuals with strong
and weak orienting response habituation. These analyses
were corrected for multiple comparisons using the
Bonferroni method (the a value divided by the number
of comparisons). In the second part of the analysis, we
investigated pAKT/AKT using an analysis of variance
(ANOVA), in which group (strong vs weak habituators)
was the between-subject factor and stimulation condition
(baseline vs NRG1 stimulation) was the within-subject
factor. Scheffe´’s tests were used for post hoc compari-
sons. In the third part of analysis, we investigated the fac-
tors that predicted the level of delusional ideation. In this
forward stepwise linear regression analysis, the depen-
dent variable was the PDI score, and the independent
(predictor) variables were age, education, gender, IQ,
BAI, BDI, and pAKT/AKT (baseline and NRG1 stimu-
lated). The level of significance was set at a < .05.
Results
Demographic Parameters, Inventory Scores, and Skin
Conductance Habituation
The demographic data and results from the inventories
are depicted in table 1. The distribution of the habitua-
tion index and the PDI scores are shown in figure 1. The
mean habituation index in the strong habituator group
was 0.48 lS (SD = 0.22, trial 1: 0.60 lS, trial 3: 0.12
lS), whereas in the weak habituator group this value
was 0.15 lS (SD = 0.13, trial 1: 0.42 lS, trial 3: 0.57
lS). In the whole sample, the mean total PDI score
was 51.6 (SD = 22.3), which is similar to the published
norms.25 Strong and weak habituators did not differ in
age, gender, education, IQ, and BDI scores. However,
weak habituators displayed higher scores on BAI and
PDI compared with strong habituators, suggesting
more pronounced anxiety and paranoid ideation in
weak habituators (table 1).
pAKT/AKT Ratio in Strong and Weak Habituators
TheANOVA conducted on the pAKT/AKT revealed sig-
nificant main effects of group (strong vs weak habitua-
tors) (F1,118 = 9.93, P < .01) and condition (baseline vs
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NRG1 stimulated) (F1,118 = 14.94, P < .001). The interac-
tion between group and condition was significant (F1,118 =
32.96, P < .0001). Scheffe´’s test indicated that the 2
groups did not differ in the baseline condition (P = .9).
In contrast, in the NRG1-stimulated condition, the
weak habituators had significantly lower pAKT/AKT ra-
tio compared with that of the strong habituators (P <
.0001). In strong habituators, NRG1 significantly in-
creased the pAKT/AKT ratio (P < .0001), whereas in
weak habituators this effect was absent (P = .7) (figure 2).
Predictors of Delusional Ideation
The forward stepwise multiple regression analysis
revealed that the habituation index was the best predictor
of PDI scores (F1,118 = 49.57, P < .0001, R
2 change =
0.30) (Figure 1). The second was NRG1-stimulated
pAKT/AKT ratio (F1,118 = 24.68, P< .0001, R
2 change =
0.12), and the third was BAI scores (F1,118 = 12.68, P <
.001,R2 change = 0.06). Age, education, gender, IQ, BDI
scores, and baseline pAKT/AKT ratio did not predict
PDI scores (F < 2, P > .1).
Discussion
In this study, we investigated the relationship between
NRG1-induced AKT phosphorylation and markers of
psychosis proneness in nonclinical individuals. As
expected from previous studies, participants with weak
habituation of arousal displayed more paranoid ideation
than strong habituators,2 and the habituation index
accounted for 30% of variance of the PDI. The key find-
ing of the study was that the pAKT/AKT ratio after
NRG1 induction was also lower in weak habituators
than in strong habituators and accounted for 12% of var-
iance of the PDI. These predictors could be promising,
but the underlying mechanism leading to psychosis
proneness and even psychosis needs further investigation.








Gender (male/female) 13/20 45/42
Age (y) 30.4 (7.4) 29.3 (6.5)
Education (y) 11.4 (3.6) 11.9 (3.2)
IQ 109.9 (15.1) 110.8 (11.0)
BDI 7.2 (3.1) 6.4 (3.3)
BAI* 10.0 (5.2) 6.7 (3.7)
PDI** 74.3 (19.0) 43.6 (16.2)
Note: Data are mean (SD) with the exception of gender
distribution. Means were compared with 2-tailed t tests; gender
distributions were compared with a v2 test. IQ was measured by
the revised version of the Wechsler Adult Intelligence Scale.
BDI, Beck Depression Inventory, BAI, Beck Anxiety Inventory,
PDI, Peters et al. Delusion Inventory.
*t118 = 3.88, P < .001; **t118 = 8.83, P < .0001.
Fig. 1. The central correlation graph shows the relationship between the Peters et al. Delusion Inventory (PDI) scores and the habituation
index.Theupperpanel of the figure shows thedistribution (numberof observed cases) of thePDI scores,which are depictedon thehorizontal
axis of the central correlationgraph.The right-sidepanel shows thedistributionof thehabituation index,which is depictedon the vertical axis
of the central correlation graph.
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Thefinding that thepAKT/AKTratio is lower inpsycho-
sis-proneindividuals isconsistentwiththedataofEmamian
et al20 and Sei et al10 who described similar phenomena in
patients with schizophrenia. However, some differences
should be mentioned. Emamian et al20 demonstrated de-
creased AKT protein levels in the peripheral lymphocytes
and brains of patients with schizophrenia, a significant as-
sociationbetweenschizophreniaandanAKThaplotypeas-
sociated with lower AKT protein levels and a greater
sensitivity to the sensorimotor gating-disruptive effect of
amphetamine related to AKT deficiency. The decreased
AKTprotein level and its association with genetic variants
were not replicated ina Japanesepopulationof schizophre-
nia patients.30 Ide et al30 also found unaltered pAKT/AKT
ratio in the lymphocytesof schizophreniapatients.Thepar-
adigmofSeietal10wentfurtherandinvestigatedtheeffectof
NRG1 stimulation on AKT phosphorylation, which may
be a more specific marker. In the baseline (nonstimulated)
conditionof Sei et al,10 the pAKT/AKTratiodifference be-
tween patients with schizophrenia and controls was small,
whereas in the NRG1-stimulated condition, the pAKT/
AKT ratio was approximately 4 times higher in controls
than in patients with schizophrenia. We observed a highly
similar pattern in nonclinical individuals with higher delu-
sional ideationsandweakerhabituation:Thesepersonsdif-
fered from less delusional strong habituators only in the
NRG1-stimulated condition but not in the baseline condi-
tion (Figure 1).
It is interesting that NRG1-induced AKT phosphory-
lation is also influenced by the genetic polymorphism of
the COMT gene (Val108/158Met)10,31. Specifically,
NRG1-induced AKT phosphorylation is significantly
impaired in Val carriers compared with Met carriers in
both healthy subjects and patients with schizophrenia,
which may indicate that poorer NRG1-induced cell
adhesion and migration in Val carriers are due at least
in part to decreased AKT activation10,31. At the level
of symptoms, this polymorphism may be associated
with anxiety-spectrum phenotypes.32
The causal relationship betweenNRG1, AKT, and ori-
enting response habituation remains elusive. In this
study, a relatively indirect system was applied to measure
AKT phosphorylation induced by exogenous NRG1 in B
lymphoblasts. Even though both NRG1 and AKT seem
to be implicated in the pathophysiology of schizophrenia,
the underlying signaling cascades from NRG1 to AKT
are complex. At the behavioral level, evidence suggests
that that NRG1 is important in sensory inhibition and
adaptation when repeated stimuli evoke smaller
responses. Hong et al33 found that a missense mutation
of the NRG1 gene is associated with impaired prepulse
inhibition in healthy individuals and in patients with
schizophrenia. This is consistent with rodent models in
which NRG1 heterozygous animals showed significantly
impaired prepulse inhibition.34 Recently, Chen et al35
demonstrated that the type III isoform of NRG1 is re-
quired to maintain normal sensory gating, which is
a marker of the integrity of corticostriatal circuits. In
the original study of Emamian et al,20 the deficit of
AKT was also related to sensorimotor gating disturban-
ces. The PI3K/AKT system is important in dopaminergic
and glutamatergic neurotransmission,36,37 and AKT
is linked to dopamine-related prefrontal functions
and structural alterations similar to those found in
schizophrenia.38,39
Previous studies suggested that there is a relationship
between anxiety and psychosis-like experiences,40,41 with
a special reference to persecutory delusions.42,43 How-
ever, the results are not consistent. For example, Allen
et al2 did not find significant differences in BAI scores
between weak and strong habituators with high and
low psychosis proneness, respectively. These discrepan-
cies may be due to differences in the characteristics of
the individuals included in separate studies or may be
the consequence of low statistical power. In our study,
weak habituators showed higher anxiety than strong
habituators, and anxiety was an independent predictor
of delusional ideation in addition to the habituation
index and NRG1-stimulated pAKT/AKT.
Conclusions
In summary, we used a combined approach to character-
ize psychosis proneness in nonclinical individuals. This
included the measurement of the peripheral modulation
of intracellular signal transduction associated with
Fig. 2.Mean phosphorylatedAKT (pAKT)/AKT ratios at baseline
and after neuregulin 1 (NRG1) stimulation in weak and strong
habituators.Errorbars indicate95%confidence intervals.Thepanel
illustrates results from the immunoblot analysis showing AKT and
pAKT bands from the weak and strong habituator groups after
stimulation.
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psychotic disorders (NRG1-induced AKT phosphoryla-
tion), a physiological marker (habituation of autonomic
arousal), and self-report rating scales of subjective expe-
riences (overvalued ideas and emotional distress). The
results revealed a characteristic pattern of relationships
among these measures, which raises the possibility that
such a combined approach may be useful for future stud-
ies aimed at investigating psychosis proneness and psy-
chosis risk factors in the general population.
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